县域医共体下多模态CT检查在醒后卒中患者中的推广应用

注册号:

Registration number:

ChiCTR2500099154 

最近更新日期:

Date of Last Refreshed on:

2025-03-19 11:22:28 

注册时间:

Date of Registration:

2025-03-19 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

县域医共体下多模态CT检查在醒后卒中患者中的推广应用

Public title:

The application of multimodal CT examination in wake-up stroke patients in county medical community

注册题目简写:

English Acronym:

研究课题的正式科学名称:

县域医共体下多模态CT检查在醒后卒中患者中的推广应用

Scientific title:

The application of multimodal CT examination in wake-up stroke patients in county medical community

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

曹军 

研究负责人:

曹军 

Applicant:

Jun Cao 

Study leader:

Jun Cao 

申请注册联系人电话:

Applicant telephone:

+86 137 0658 0621

研究负责人电话:

Study leader's
telephone:

+86 137 0658 0621

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

158428483@qq.com

研究负责人电子邮件:

Study leader's E-mail:

158428483@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省海盐县武原街道盐湖西路901号

研究负责人通讯地址:

浙江省海盐县武原街道盐湖西路901号

Applicant address:

Department of Radiology, Haiyan County People's Hospital, Zhejiang Province

Study leader's address:

Department of Radiology, Haiyan County People's Hospital, Zhejiang Province

申请注册联系人邮政编码:

Applicant postcode:

314300

研究负责人邮政编码:

Study leader's postcode:

314300

申请人所在单位:

海盐县人民医院

Applicant's institution:

Haiyan County People's Hospital

研究负责人所在单位:

海盐县人民医院

Affiliation of the Leader:

Haiyan County People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2023年度)伦审研 第(05)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

海盐县人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Haiyan County People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-07-18 00:00:00

伦理委员会联系人:

邬梅珍

Contact Name of the ethic committee:

Meizhen Wu

伦理委员会联系地址:

浙江省海盐县武原街道盐湖西路901号

Contact Address of the ethic committee:

Department of Radiology, Haiyan County People's Hospital, Zhejiang Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 573 8622 9442

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

海盐县人民医院

Primary sponsor:

Haiyan County People's Hospital

研究实施负责(组长)单位地址:

浙江省海盐县武原街道盐湖西路901号

Primary sponsor's address:

901 Yanhu West Road, Wuyuan Street, Haiyan County, Zhejiang Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

Country:

China

Province:

Zhejiang

City:

单位(医院):

海盐县人民医院

具体地址:

浙江省海盐县武原街道盐湖西路901号

Institution
hospital:

Haiyan County People's Hospital

Address:

901 Yanhu West Road, Wuyuan Street, Haiyan County, Zhejiang Province

经费或物资来源:

单位资助

Source(s) of funding:

Hospital funding

研究疾病:

急性缺血性脑卒中  

Target disease:

Acute ischemic stroke

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

(1)评价全脑CT灌注扫描联合头颈部CTA的多模态CT检查技术在指导临床治疗WUS患者和SWA患者中的应用效果及其临床价值。 (2)在县域医共体下推广多模态CT检查技术,优化流程,减少检查时间,缩短病人到达医院到再灌注治疗时间。  

Objectives of Study:

1. To evaluate the application effect and clinical value of the multimodal CT technique of whole brain CT perfusion scanning combined with head and neck CTA in guiding the clinical treatment of WUS patients and SWA patients. 2. Multi-modal CT examination technology should be promoted in the county medical community to optimize the process, reduce the examination time, and shorten the time from patient arrival to reperfusion treatment.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.颅脑CT提示颅内出血或蛛网膜下腔出血、其他部位活动性出血或有明显出血倾向; 2.严重心、肝、肾功能不全; 3.妊娠期者; 4.碘对比剂过敏者; 5.溶栓治疗和机械取栓治疗禁忌症者; 6.药物无法控制的严重高血压; 7.头颅平扫CT、CTP或头颈部CTA图像存在严重伪影者。

Exclusion criteria:

1. Cranial CT showed intracranial hemorrhage or subarachnoid hemorrhage, active bleeding in other parts or obvious bleeding tendency; 2. Severe cardiac, hepatic and renal insufficiency; 3. Pregnant; 4. Those who are allergic to iodine contrast medium; 5. Patients with contraindications to thrombolytic therapy and mechanical thrombectomy; 6. Severe hypertension that cannot be controlled by medications; 7. Those with serious artifacts in the CT, CTP or head and neck CTA images of the head and neck.

研究实施时间:

Study execute time:

From 2023-12-25 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-04-01 00:00:00 To 2026-12-31 00:00:00

干预措施:

Interventions:

组别:

醒后卒中组

样本量:

50

Group:

Wake-up stroke group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

清醒时卒中组

样本量:

50

Group:

Stroke while awake group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

海盐县人民医院 

单位级别:

三乙 

Institution
hospital:

Haiyan County People's Hospital

Level of the institution:

Tertiary B

测量指标:

Outcomes:

指标中文名:

卒中后 90 d 改良 Rankin 量表(mRS)评分

指标类型:

主要指标

Outcome:

The modified Rankin scale (mRS) at 90 days after stroke was evaluated

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

再灌注后 24 h、7 d 的NIHSS评分

指标类型:

次要指标

Outcome:

NIHSS scores at 24 h and 7 d after reperfusion were recorded

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

复查头颅CT或MRI检查是否存在永久性缺血性脑组织

指标类型:

附加指标

Outcome:

Head CT or MRI was reexamined for the presence of permanent ischemic brain tissue

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表结合电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Combining electronic data collection and management system for case records

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-03-19 11:22:21